Brainify.AI
New York, NY
Brainify.AI is a decision support tool for depression screening and treatment decisions. Brainify is examining EEG-biomarkers to diagnose depression, determine the stage and type of the disorder, and predict treatment response. No two brains are identical; therefore, Brainify changes a paradigm from “one-size-fits-all” psychiatry to more personalized treatment to enable patients to receive the best Rx medication. Our product relies on two decades of scientific research in psychiatry, neuroscience, and psychopharmacology
brainify.aiCompany Details
Founded
- 2021
Employees
- Between 10 - 50 employees
Raised
- $1,600,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Mariam Khayretdinova
Founders
- Ivan MishaninMariam Khayretdinova
Company Collections
These are collections Brainify.AI is a part of. Click on the collection name to view similar companies.